Create Medic Co., Ltd. (5187.T)
JPY 939.0
(3.41%)
JPY 939.0
(3.41%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 698.83 Million | 461.34 Million | 1.24 Billion | 1.24 Billion | 880.33 Million | 797.92 Million |
| Net Income | 154.02 Million | 836.74 Million | 965.62 Million | 984.38 Million | 1.1 Billion | 980.16 Million |
| Depreciation & Amortization | 588.14 Million | 600.25 Million | 462.46 Million | 405.88 Million | 389.96 Million | 348.77 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -455.41 Million | -541.98 Million | -21.75 Million | 190.5 Million | -175.84 Million | -313.03 Million |
| Other non-cash items | 412.07 Million | -433.66 Million | -157.65 Million | -331.75 Million | -435.36 Million | -217.98 Million |
| Investing Cash Flow | -363.61 Million | 38.01 Million | -585.01 Million | -704.3 Million | -511.63 Million | -598.59 Million |
| Investments in PPE | -451.85 Million | -359.59 Million | -619.09 Million | -410.01 Million | -247 Million | -444.43 Million |
| Acquisitions | 86.5 Million | 21.34 Million | -320.36 Million | -182.11 Million | 1.69 Million | 8.82 Million |
| Investment purchases | -213.1 Million | -323.1 Million | -500 Thousand | -331.19 Million | -266.7 Million | -163.23 Million |
| Sales/Maturities of investments | 213.1 Million | 693.79 Million | 36.12 Million | 34.84 Million | -1.69 Million | - |
| Other Investing Activities | 1.74 Million | 5.57 Million | 318.83 Million | 184.17 Million | 2.07 Million | 9.07 Million |
| Financing Cash Flow | -362.19 Million | -355.58 Million | -442.51 Million | -845.03 Million | -532.58 Million | -585.58 Million |
| Debt repayment | -26.42 Million | -23.98 Million | -92.4 Million | -266.4 Million | -166.4 Million | -459.47 Million |
| Dividends payments | -335.7 Million | -336.04 Million | -335.85 Million | -344.39 Million | -353.04 Million | -326.04 Million |
| Common Stock Repurchased | -62 Thousand | -18 Thousand | -157 Thousand | -222.39 Million | -116 Thousand | -74 Thousand |
| Common Stock Issuance | - | 4.45 Million | -14.1 Million | -11.84 Million | -13.02 Million | 200 Million |
| Other Financing Activities | -1000.00 | -1000.00 | -2000.00 | -1000.00 | -1000.00 | -1000.00 |
| Accounts receivables | 100.95 Million | 37.52 Million | -167.17 Million | 29.04 Million | 35.32 Million | -19.86 Million |
| Accounts payables | -28.03 Million | 81.87 Million | -31.08 Million | 70.92 Million | -165.96 Million | -16.51 Million |
| Inventory | -346.24 Million | -505.55 Million | 77.25 Million | -79.51 Million | -82.25 Million | -368.18 Million |
| Other working capital | -182.09 Million | -155.83 Million | 99.24 Million | 170.05 Million | 37.04 Million | 55.14 Million |
| Cash at beginning of period | 3.7 Billion | 3.41 Billion | 3.08 Billion | 3.42 Billion | 3.62 Billion | 4.11 Billion |
| Cash at end of period | 3.77 Billion | 3.7 Billion | 3.41 Billion | 3.08 Billion | 3.42 Billion | 3.62 Billion |
| Capital Expenditure | -451.85 Million | -359.59 Million | -619.09 Million | -410.01 Million | -247 Million | -444.43 Million |
| Effect of forex changes on cash | 95.43 Million | 144.83 Million | 109.17 Million | -42.85 Million | -39.37 Million | -98.47 Million |
| Net cash flow / Change in cash | 68.46 Million | 288.6 Million | 330.32 Million | -343.17 Million | -203.26 Million | -484.73 Million |
| Free Cash Flow | 246.98 Million | 101.75 Million | 629.58 Million | 839 Million | 633.32 Million | 353.48 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 491 Million | 59 Million | 145 Million | 154.02 Million | -307 Million | 187 Million |
| Depreciation & Amortization | - | - | 160.42 Million | 588.14 Million | 139.18 Million | 139.44 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | -455.41 Million | - | - |
| Other non-cash items | -491 Million | -59 Million | -145 Million | 412.07 Million | 307 Million | -187 Million |
| Investing Cash Flow | - | - | - | -363.61 Million | - | - |
| Investments in PPE | - | - | - | -451.85 Million | - | - |
| Acquisitions | - | - | - | 86.5 Million | - | - |
| Investment purchases | - | - | - | -213.1 Million | - | - |
| Sales/Maturities of investments | - | - | - | 213.1 Million | - | - |
| Other Investing Activities | - | - | - | 1.74 Million | - | - |
| Financing Cash Flow | - | - | - | -362.19 Million | - | - |
| Debt repayment | - | - | - | -26.42 Million | - | - |
| Dividends payments | - | - | - | -335.7 Million | - | - |
| Common Stock Repurchased | - | - | - | -62 Thousand | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | -1000.00 | - | - |
| Accounts receivables | - | - | - | 100.95 Million | - | - |
| Accounts payables | - | - | - | -28.03 Million | - | - |
| Inventory | - | - | - | -346.24 Million | - | - |
| Other working capital | - | - | - | -182.09 Million | - | - |
| Cash at beginning of period | - | - | 4.16 Billion | 3.7 Billion | 3.43 Billion | 4.32 Billion |
| Cash at end of period | - | - | 4.39 Billion | 3.77 Billion | 4.16 Billion | 3.43 Billion |
| Capital Expenditure | - | - | - | -451.85 Million | - | - |
| Effect of forex changes on cash | - | - | - | 95.43 Million | - | - |
| Net cash flow / Change in cash | - | - | 226.57 Million | 68.46 Million | 728.48 Million | -890.26 Million |
| Free Cash Flow | - | - | 320.85 Million | 246.98 Million | 278.37 Million | 278.88 Million |
ETF
CGO
SMME
4004
FPH
6276